By Drs. David Niesel and Norbert Herzog
Every now and then things go right, really, really right. In an immunotherapy clinical trial, 27 of the 29 leukemia patients went into sustained remissions, which is a whopping 93 percent success rate!
Acute lymphocytic leukemia, or ALL, is a cancer that arises in the bone marrow, the soft center of flat bones. In the bone marrow, blood stem cells give rise to all blood cells. ALL arises from the cells that become lymphocytes, a type of white blood cell. Acute in the name means that it can progress quickly and if not treated can be fatal within a few months. If the ALL cancer cells occupy more than 25% of the bone marrow, the disease is called leukemia.
Lymphocytes are a major part of the immune system found in lymphoid tissues as well as circula…